Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical tools for BAZ2A/B biology: discovery of dual and BAZ2B-selective PROTAC degraders. | RSC Med Chem | 2026 | 42626597 | PubTator, text mining | PubMed |
| Development of Cereblon (CRBN) as an early prognostic biomarker in Paediatric Sepsis: a Prospective Observational Study Protocol. | BMJ Open | 2026 | 42613111 | PubTator, text mining | PubMed |
| Novel VHL ligand-based PROTACs targeting JNK1: design, synthesis, and biological evaluation with potent anti-EMT activity. | Bioorg Chem | 2026 | 42612267 | PubTator, text mining | PubMed |
| The PROTAC milestone: FDA approval of vepdegestrant (ARV-471) for ESR1-mutated breast cancer. | Drug Discov Today | 2026 | 42603649 | PubTator, text mining | PubMed |
| Proteome-wide identification of the druggable CRBN interactome. | Nat Biotechnol | 2026 | 42595817 | PubTator, text mining | PubMed |
| PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells. | Cancers (Basel) | 2026 | 42588596 | PubTator, text mining | PubMed |
| From undruggable to degradable: development of anthraquinone-based PROTACs against MITF for skin-lightening applications. | J Asian Nat Prod Res | 2026 | 42579764 | PubTator, text mining | PubMed |
| Chemical and Enzymatic Approaches to C-Terminal Cyclic Imide Formation. | Methods Mol Biol | 2026 | 42573690 | PubTator, text mining | PubMed |
| Utilization of Functional Degradation Pathways for the Characterization of Ubiquitin-Proteasome System Tool Compounds. | Methods Mol Biol | 2026 | 42573688 | PubTator, text mining | PubMed |
| Binding Modes of Thalidomide Derivatives in Cereblon-Neosubstrate Complexes Revealed by Molecular Dynamics and Free Energy Calculations. | ACS Omega | 2026 | 42540317 | PubTator, text mining | PubMed |
| Selective and Potent First-in-Class CRBN-Dependent Molecular Glue Degraders of WW Domain-Binding Protein 4. | Angew Chem Int Ed Engl | 2026 | 42520189 | PubTator, text mining | PubMed |
| Linker attachment points: "finishing touch" in PROTAC design. | RSC Med Chem | 2026 | 42519712 | PubTator, text mining | PubMed |
| Computational mapping of productive POI-E3 ligase conformations to guide de novo degrader design: application to WEE1 and PKMYT1 PROTACs. | J Cheminform | 2026 | 42509556 | PubTator, text mining | PubMed |
| In Silico Analysis of Enantioselective Binding of Pomalidomide Targets for Multiple Myeloma. | Chirality | 2026 | 42470200 | PubTator, text mining | PubMed |
| Two Mechanisms One Molecule: Developing a 'Truly' Bifunctional Degrader Targeting Rpn13 and CRBN. | J Am Chem Soc | 2026 | 42467896 | PubTator, text mining | PubMed |
| The synthetic landscape of cereblon (CRBN) binders: from thalidomide to emerging chemotypes. | Chem Soc Rev | 2026 | 42444470 | PubTator, text mining | PubMed |
| An Optimized and Improved Protocol for Efficient Isolation of Extracellular RNA from Human Serum. | Curr Protoc | 2026 | 42434999 | PubTator, text mining | PubMed |
| Potent and isoform-selective PARP1 degraders for the treatment of BRCA-deficient cancers. | Bioorg Chem | 2026 | 42419053 | PubTator, text mining | PubMed |
| GID4-Recruiting PROTACs for BRD4 Degradation Overcome Resistance Driven by CRBN and VHL Deficiency. | J Med Chem | 2026 | 42402035 | PubTator, text mining | PubMed |
| NSD2 degradation remediates the oncogenic cistrome in t(4;14) multiple myeloma. | Blood | 2026 | 42371798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=2